Dr. Kevin M. Holcomb, MD

Dr. Holcomb practices at New Hyde Park Endoscopy in Lake Success, New York.

Dr. Holcomb's NPI, 1952307266, was assigned on June 22, 2005. Dr. Holcomb graduated from New York Medical College in 1992. Dr. Holcomb holds New York license 201452.

Dr. Holcomb's primary practice is New Hyde Park Endoscopy, at 1991 Marcus Avenue, Lake Success, NY 11042. The practice phone is (317) 796-7565.

Dr. Holcomb's primary practice is New Hyde Park Endoscopy in Lake Success, New York. Dr. Holcomb is also affiliated with Long Island Jewish Medical Center. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Holcomb to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Holcomb practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Holcomb's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Holcomb is licensed in New York.

CMS data shows 125 Medicare services from Dr. Holcomb across 3 procedure codes in 2024, for 80 Medicare patients. Medicare paid $8,387 for them. Every service was in an office.

CMS counts 80 Medicare patients who saw Dr. Holcomb in 2024. The largest group is 75 to 84, with 38 patients. 75% of them have high cholesterol, and 66% have cancer. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Holcomb's median patient age at 64, with 98% women.

In 2024, Dr. Holcomb wrote 14 Medicare Part D claims. They cover 1 drug, with $282,005 in total drug cost. In 2021, CMS named 31 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Holcomb for performance year 2024, reported through an alternative payment model (APM). Dr. Holcomb accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 109 papers to Dr. Holcomb, published from 2011 to 2024. 2020 was the busiest year, with 14. The most frequent topics are Ovarian Neoplasms, Endometrial Neoplasms and Hysterectomy. Dr. Holcomb has published most often in Gynecol Oncol. Dr. Holcomb's most frequent co-authors are Eloise Chapman-Davis, MD, Melissa Kristen Frey, MD and Thomas A. Caputo, MD.

Dmand AI links Dr. Holcomb to 6 clinical trials, 3 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Carcinosarcoma, Ovarian Neoplasms and Neoplasms, Complex and Mixed. National Cancer Institute (NCI) sponsors the most, 3.

CMS Open Payments shows 23 general payments to Dr. Holcomb from 11 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 93% of the total. Abbott Laboratories paid the most, $13,000.

Dr. Holcomb graduated from New York Medical College in 1992.